Christian Doppler Laboratory for Antibody Engineering, Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna (BOKU), Muthgasse 18, 1190 Vienna, Austria.
Protein Engineering and Antibody Technologies, EMD Serono Research and Development Institute, Inc., 45A Middlesex Turnpike, Billerica, MA 01821, USA.
Biochim Biophys Acta Proteins Proteom. 2020 Jan;1868(1):140250. doi: 10.1016/j.bbapap.2019.07.003. Epub 2019 Jul 8.
Bispecific antibodies promise to broadly expand the clinical utility of monoclonal antibody technology. Several approaches for heterodimerization of heavy chains have been established to produce antibodies with two different Fab arms, but promiscuous pairing of heavy and light chains remains a challenge for their manufacturing.
We have designed a solution in which the C1 and C domain pair in one of the Fab fragments is replaced with a C3-domain pair and heterodimerized to facilitate correct modified Fab-chain pairing in bispecific heterodimeric antibodies based on a strand-exchange engineered domain (SEED) scaffold with specificity for epithelial growth factor receptor and either CD3 or CD16 (FcγRIII).
Bispecific antibodies retained binding to their target antigens and redirected primary T cells or NK cells to induce potent killing of target cells. All antibodies were expressed at a high yield in Expi293F cells, were detected as single sharp symmetrical peaks in size exclusion chromatography and retained high thermostability. Mass spectrometric analysis revealed specific heavy-to-light chain pairing for the bispecific SEED antibodies as well as for one-armed SEED antibodies co-expressed with two different competing light chains.
Incorporation of a constant domain-exchanged Fab fragment into a SEED antibody yields functional molecules with favorable biophysical properties.
Our results show that the novel engineered bispecific SEED antibody scaffold with an incorporated Fab fragment with C3-exchanged constant domains is a promising tool for the generation of complete heterodimeric bispecific antibodies with correct light chain pairing.
双特异性抗体有望广泛扩大单克隆抗体技术的临床应用。已经建立了几种重链异二聚化的方法来产生具有两个不同 Fab 臂的抗体,但重链和轻链的混杂配对仍然是其制造的一个挑战。
我们设计了一种解决方案,其中一个 Fab 片段的 C1 和 C 结构域对被 C3 结构域对取代,并进行异二聚化,以促进基于具有表皮生长因子受体特异性的链交换工程结构域 (SEED) 支架的双特异性异二聚体抗体中正确修饰的 Fab 链配对,以及 CD3 或 CD16(FcγRIII)。
双特异性抗体保留了与其靶抗原的结合,并将原代 T 细胞或 NK 细胞重定向,以诱导对靶细胞的有效杀伤。所有抗体在 Expi293F 细胞中均以高产率表达,在分子筛层析中检测为单一尖锐对称的峰,且保留了高热稳定性。质谱分析显示,双特异性 SEED 抗体以及与两种不同竞争轻链共表达的单臂 SEED 抗体均具有特异性的重链与轻链配对。
将恒定结构域交换的 Fab 片段纳入 SEED 抗体中可产生具有有利的物理化学性质的功能性分子。
我们的结果表明,具有掺入的 C3 交换恒定结构域的 Fab 片段的新型工程化双特异性 SEED 抗体支架是生成具有正确轻链配对的完整异二聚体双特异性抗体的有前途的工具。